M&A Deal Summary

Grifols Acquires Hologic - NAT

On December 14, 2016, Grifols acquired test/measurement equipment company Hologic - NAT from Hologic for 1.9B USD

Acquisition Highlights
  • This is Grifols’ 1st transaction in the Test/Measurement Equipment sector.
  • This is Grifols’ largest (disclosed) transaction.
  • This is Grifols’ 3rd transaction in the United States.

M&A Deal Summary
Date 2016-12-14
Target Hologic - NAT
Sector Test/Measurement Equipment
Buyer(s) Grifols
Sellers(s) Hologic
Deal Type Divestiture
Deal Value 1.9B USD

Target

Hologic - NAT

United States
Hologic - NAT (Nucleic Acid Testing) is the most advanced technology for the detection of infectious agents in blood and plasma donations because they are much more sensitive in detecting viral infections and reducing the so-called window period, interval between donor exposure to a virus and production of antibodies against the virus. In terms of diagnostic, NAT tests reduce this window period, increasing the diagnostics transfusion safety.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Grifols

Barcelona, Spain
Category Company
Founded 1909
Sector Healthcare Services
Employees23,000
Revenue 6.6B EUR (2023)
DESCRIPTION

Grifols is a global healthcare company and biopharmaceutical manufacturer. Grifols was founded in 1909 and is based in Barcelona, Spain.

DEAL STATS #
Overall 4 of 8
Sector (Test/Measurement Equipment) 1 of 1
Type (Divestiture) 2 of 3
Country (United States) 3 of 6
Year (2016) 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-04 Alkahest

San Carlos, California, United States

Alkahest is focused on developing therapies derived from blood to treat neurological diseases, with an emphasis on the age-related cognitive decline key medical challenges. The company’s research has demonstrated that factors in the blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimer’s disease models in mice. Alkahest was formed in 2014 and is based in San Carlos, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-05 GigaGen

South San Francisco, California, United States

GigaGen is a biotechnology company specialized in the early discovery and development of recombinant biotherapeutic medicines. GigaGen’s research focuses on discovering new biological treatments based on antibodies derived from millions of immune system cells obtained from donors. GigaGen currently spearheads several in-house research projects, including the development of the world’s first recombinant polyclonal immunoglobulin and a portfolio of immuno-oncological therapies.

Buy -

Seller(S) 1

SELLER

Hologic

Marlborough, Massachusetts, United States
Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 3 of 4
Sector (Test/Measurement Equipment) 1 of 1
Type (Divestiture) 3 of 4
Country (United States) 3 of 4
Year (2016) 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-03 Hologic - LIFECODES business

United States

Hologic - LIFECODES business includes transplantation diagnostics. LIFECODES sells molecular and antibody-based assays in the markets of transplant diagnostics, specialty coagulation and transfusion medicine.

Sell $85M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-14 Cynosure

Westford, Massachusetts, United States

Cynosure is a developer and marketer of aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure was founded in 1991 and is based in Westford, Massachusetts.

Buy $1.7B
Mergr

Product

Company

Legal